Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Revolution Medicines Inc shares valued at $79,624 were sold by Cislini Jeff on Sep 24 ’25. At $44.26 per share, Cislini Jeff sold 1,799 shares. The insider’s holdings dropped to 50,425 shares worth approximately $2.4 million following the completion of this transaction.
Also, JEFFREY TODD CISLINI purchased 1,799 shares, netting a total of over 79,525 in proceeds.
Before that, Wei Lin had sold 2,160 shares from its account. In a trade valued at $98,982, the Chief Medical Officer traded Revolution Medicines Inc shares for $45.82 each. Upon closing the transaction, the insider’s holdings decreased to 2,160 shares, worth approximately $4.21 million.
Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. As of August 19, 2025, Piper Sandler has initiated its “an Overweight” rating for RVMD. Earlier on August 15, 2025, Wells Fargo initiated its rating. Their recommendation was “an Overweight” for RVMD stock.
Analyzing RVMD Stock Performance
On last trading session, Revolution Medicines Inc [NASDAQ: RVMD] plunged -0.43% to $47.62. The stock’s lowest price that day was $47.445, but it reached a high of $48.355 in the same session. During the last five days, there has been a surge of approximately 4.19%. Over the course of the year, Revolution Medicines Inc shares have jumped approximately 0.58%. Shares of the company reached a 52-week high of $49.50 on 10/08/25 and a 52-week low of $29.17 on 04/07/25.
Support And Resistance Levels for Revolution Medicines Inc (RVMD)
According to the 24-hour chart, there is a support level at 47.26, which, if violated, would cause prices to drop to 46.90. In the upper region, resistance lies at 48.17. The next price resistance is at 48.72. RSI (Relative Strength Index) is 65.82 on the 14-day chart, showing neutral technical sentiment.
Is Revolution Medicines Inc subject to short interest?
Stocks of Revolution Medicines Inc saw a sharp rise in short interest on 2025-09-15 jumping by 2.88 million shares to 18.05 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 15.18 million shares. A jump of 15.94% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.86 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.86.
Which companies own the most shares of Revolution Medicines Inc (RVMD)?
In terms of Revolution Medicines Inc share price expectations, FactSet research, analysts set an average price target of 75 in the next 12 months, up nearly 56.84% from the previous closing price of $47.82. Analysts anticipate Revolution Medicines Inc stock to reach 99 by 2025, with the lowest price target being 72. In spite of this, 13 analysts ranked Revolution Medicines Inc stock as Buy at the end of 2025. On July 15, 2025, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $65.
